Of the few remaining ILC2s in RORα-deficient mice, there was also a reduction in IL-5-producing cells within the colon (Figure 3E,F and Figure S5), suggesting that ILC2-derived cytokines may suppress CRC progression. The gene discussed is RORA; the disease is colorectal carcinoma.